Research For better living

news item:Triskelion’s transition plans and altered services portfolio as of January 1, 2019

Taken into consideration the current technical developments on pharma, food and chemical testing in combination with the Dutch and EU governmental desire to reduce animal use in testing, Triskelion has decided to redirect its focus on analytical and registration services. We will therefore discontinue our animal related services as of January 1, 2019. We will finish the ongoing projects in accordance with the quality standards as promised.

We would like to emphasize that our decision does not affect the animal related research activities of TNO (, the organization from which Triskelion originates.

The following services will no longer be offered as of January 1, 2019:

Toxicology (in vivo and in vitro)
Immunology (in vivo and in vitro)
ADME/DMPK (in vivo and in vitro)

We will focus on delivering best in class solutions in the area of

Nutrient analyses
Genetically modified Organisms (GMO) analyses
Authenticity analyses
Emergency Response Service (ERS)
Registration Services & Risk Assessment
Packaging (migration, petitioning and compliance)
TIM: gastrointestinal models (services & lease)
(Bio) analytical services (GLP and non-GLP): method development, validation and sample analyses

Triskelion takes pride in being your trusted partner in these fields of expertise. We will ensure to deliver the altered services portfolio to the highest standards applicable. During the coming months we will inform you about the next steps we will take in building our altered services portfolio. Please check our website for available updates.

Might you have any questions, please feel free to contact us: